Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Stewart

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Community Dentistry and Oral Epidemiology|January 16, 1998
The Australian public's perception of mercury risk from dental restorationsW M Thomson, J F Stewart, K D Carter, et al.
The Journal of Urology|August 1, 1996
Radical prostatectomy with preservation of urinary continenceD L Gaker, L B Gaker, J F Stewart, et al.
Australian Dental Journal|December 31, 1997
Public perception of cross-infection control in dentistryW M Thomson, J F Stewart, K D Carter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Estrogen receptor status of advanced breast cancer immediately before chemotherapy does not predict for responseJ F Stewart, J L Hayward, R D Rubens, et al.
British Medical Journal|June 9, 1979
Unknown primary adenocarcinoma: incidence of overinvestigation and natural historyJ F Stewart, M H Tattersall, R L Woods, et al.
The Medical Journal of Australia|June 16, 1979
Cis-dichlorodiammine platinum (II) in advanced ovarian carcinomaJ F Stewart, M H Tattersall, R L Woods, et al.
British Journal of Cancer|August 1, 1982
Serum sialyl transferase levels in patients with metastatic breast cancer treated by chemotherapyJ F Stewart, R D Rubens, S Hoare, et al.
American Journal of Medical Genetics|April 11, 2000
Neural tube defects and the 13q deletion syndrome: evidence for a critical region in 13q33-34J Luo, N Balkin, J F Stewart, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1983
Steroid receptors and prognosis in operable (stage I and II) breast cancerJ F Stewart, R D Rubens, R R Millis, et al.
Journal of the American Veterinary Medical Association|October 20, 1998
Use of human recombinant erythropoietin and prednisone for treatment of myelodysplastic syndrome with erythroid predominance in a dogL I Boone, K W Knauer, S W Rapp, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Community Dentistry and Oral Epidemiology|January 16, 1998
The Australian public's perception of mercury risk from dental restorationsW M Thomson, J F Stewart, K D Carter, et al.
The Journal of Urology|August 1, 1996
Radical prostatectomy with preservation of urinary continenceD L Gaker, L B Gaker, J F Stewart, et al.
Australian Dental Journal|December 31, 1997
Public perception of cross-infection control in dentistryW M Thomson, J F Stewart, K D Carter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Estrogen receptor status of advanced breast cancer immediately before chemotherapy does not predict for responseJ F Stewart, J L Hayward, R D Rubens, et al.
British Medical Journal|June 9, 1979
Unknown primary adenocarcinoma: incidence of overinvestigation and natural historyJ F Stewart, M H Tattersall, R L Woods, et al.
The Medical Journal of Australia|June 16, 1979
Cis-dichlorodiammine platinum (II) in advanced ovarian carcinomaJ F Stewart, M H Tattersall, R L Woods, et al.
British Journal of Cancer|August 1, 1982
Serum sialyl transferase levels in patients with metastatic breast cancer treated by chemotherapyJ F Stewart, R D Rubens, S Hoare, et al.
American Journal of Medical Genetics|April 11, 2000
Neural tube defects and the 13q deletion syndrome: evidence for a critical region in 13q33-34J Luo, N Balkin, J F Stewart, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1983
Steroid receptors and prognosis in operable (stage I and II) breast cancerJ F Stewart, R D Rubens, R R Millis, et al.
Journal of the American Veterinary Medical Association|October 20, 1998
Use of human recombinant erythropoietin and prednisone for treatment of myelodysplastic syndrome with erythroid predominance in a dogL I Boone, K W Knauer, S W Rapp, et al.
Pageof 6